Common use of License Restrictions and Limitations Clause in Contracts

License Restrictions and Limitations. 2.3.1. The Parties each agree that the rights granted pursuant to Section 2.1.1 do not include any rights to use or make the Catalysts, other than for the performance of Hydrogenation in the Research Field. 2.3.2. The Parties each agree that the rights granted pursuant to this Section 2.1.2 do not include any rights to use, manufacture, offer for sale, sell, or export the Catalysts, other than for the performance of Hydrogenation in the Commercial Field. 2.3.3. The Parties each agree that Bioamber shall make no use of the Catalysts, other than for the performance of Hydrogenation in the Research Field or for the performance of Hydrogenation in the Commercial Field, as licensed hereunder 2.3.4. The Parties each agree that the Licensed Intellectual Property contains no information concerning the production or use of [***]. The Parties each agree that the rights granted pursuant to Sections 2.1.1 and/or 2.1.2 do not include any rights to produce [***]. This Section, however, shall not be construed to restrict Bioamber or its customers from using for any purpose the Hydrogenation Products made or produced pursuant to this Agreement. . 2.3.5. The Parties each agree that Bioamber shall make no use of the rights granted pursuant to Sections 2.1.1 and/or 2.1.2 and or the Licensed Intellectual Property to produce or use [***]. 2.3.6. The Parties each agree that Bioamber shall not make any use of the Licensed Intellectual Property outside the scope of the rights granted in Sections 2.1.1 and 2.1.2. 2.3.7. The Parties each agree that DuPont has made no representation that the Licensed Intellectual Property contains information concerning the production or use of [***] or that the rights granted in Sections 2.1.1 and 2.1.2 will allow Bioamber to make any use of the Licensed Intellectual Property outside the scope of the rights granted in Sections 2.1.1 and 2.1.2 or to produce [***].

License Restrictions and Limitations. 2.3.1. The Parties each agree that the rights granted pursuant to Section 2.1.1 do not include any rights to use or make the Catalysts, other than for the performance of Hydrogenation in the Research Field. 2.3.2. The Parties each agree that the rights granted pursuant to this Section 2.1.2 do not include any rights to use, manufacture, offer for sale, sell, or export the Catalysts, other than for the performance of Hydrogenation in the Commercial Field. 2.3.3. The Parties each agree that Bioamber shall make no use of the Catalysts, other than for the performance of Hydrogenation in the Research Field or for the performance of Hydrogenation in the Commercial Field, as licensed hereunder 2.3.4. The Parties each agree that the Licensed Intellectual Property contains no information concerning the production or use of [***]] or any other downstream products produced from the Hydrogenation Products. The Parties each agree that the rights granted pursuant to Sections 2.1.1 and/or 2.1.2 do not include any rights to produce [***]] or any other downstream products from the Hydrogenation Products. This Section, however, shall not be construed to restrict Bioamber or its customers from using for any purpose the Hydrogenation Products made or produced pursuant to this Agreement. . 2.3.5. The Parties each agree that Bioamber shall make no use of the rights granted pursuant to Sections 2.1.1 and/or 2.1.2 and or the Licensed Intellectual Property to produce or use [***]] or any downstream products produced from the Hydrogenation Products. 2.3.6. The Parties each agree that Bioamber shall not make any use of the Licensed Intellectual Property outside the scope of the rights granted in Sections 2.1.1 and 2.1.2. 2.3.7. The Parties each agree that DuPont has made no representation that the Licensed Intellectual Property contains information concerning the production or use of [***] or any downstream products produced from the Hydrogenation Products or that the rights granted in Sections 2.1.1 and 2.1.2 will allow Bioamber to make any use of the Licensed Intellectual Property outside the scope of the rights granted in Sections 2.1.1 and 2.1.2 or to produce [***]] or any downstream products from the Hydrogenation Products.